Related Experiment Video

Updated: Aug 22, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
06:31

Transuterine Fetal Tracheal Occlusion Model in Mice

Published on: February 5, 2021

[Congenital diaphragmatic hernia]

Masaki Nio1

  • 1Department of Surgery, Miyagi Children's Hospital, Sendai, Japan.

Kyobu Geka. the Japanese Journal of Thoracic Surgery
|September 15, 2004
PubMed

Insights

Treatment for congenital diaphragmatic hernia (CDH) has advanced, shifting from emergent to delayed repairs. New respiratory management and fetal interventions show promise, improving survival rates for neonates with CDH.

Area of Science:

  • Pediatric Surgery
  • Neonatology
  • Fetal Medicine

Context:

  • Congenital diaphragmatic hernia (CDH) presents significant challenges in neonates, particularly early onset within 24 hours of life.
  • Historically, CDH repair was an emergent procedure, but recent trends favor delayed surgical intervention.
  • Management strategies have evolved, incorporating advanced respiratory support and surgical techniques.

Purpose:

  • To review recent advancements in the treatment of congenital diaphragmatic hernia (CDH).
  • To discuss the changing paradigms in CDH surgical timing and respiratory management.
  • To evaluate the impact of novel therapeutic approaches on CDH outcomes.

Summary:

  • The treatment of CDH has evolved, with a shift towards delayed repair and the use of advanced modalities like extracorporeal membrane oxygenation (ECMO) and high-frequency oscillatory ventilation (HFO).
  • Permissive hypercapnia and spontaneous respiration strategies aim to minimize barotrauma and improve outcomes.
  • Fetal interventions, including fetal tracheal occlusion, are being explored for severe cases, though recent studies show mixed results regarding survival benefits.

Impact:

  • Neonatal survival rates for CDH have improved, increasing from 60% to 75% over the past decade, according to Japanese pediatric surgery data.
  • Innovative approaches like minimally invasive surgery, liquid ventilation, and lung transplantation are under clinical evaluation.
  • Further research is needed to determine the long-term clinical impact of these emerging CDH treatments.

More Related Videos

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs05:40

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs

Published on: December 22, 2023

Related Concept Videos

Hiatal Hernia01:25

Hiatal Hernia

A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...